8-K

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549


                            FORM 8-K


                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported) February 12, 2004


                 COMPETITIVE TECHNOLOGIES, INC.
     (Exact name of registrant as specified in its charter)



Delaware                 1-8696                   36-2664428
(State or other          (Commission File         (IRS Employer
jurisdiction             Number)                  Identification No.)
of incorporation)




1960 Bronson Road, Fairfield, Connecticut         06824
(Address of principal executive offices)         (Zip Code)



Registrant's  telephone number, including area code   (203)  255-6044


                         Not Applicable
  (Former Name or Former Address, if Changed Since Last Report)


Item 5.   Other Events and Regulation FD Disclosure.

     On February 12, 2004, Competitive Technologies, Inc. (CTT)
reported that it had been advised that Wyeth Holdings Corporation
(a subsidiary of Wyeth formerly known as American Cyanamid
Company) filed an appeal to the United States Supreme Court in
the Materna(TM) litigation.

     (For further information related to this lawsuit, see the
discussion of Materna Litigation in Note 8 to CTT's Condensed
Financial Statements in its report on Form 10-Q for the quarterly
period ended October 31, 2003.)

Item 7.   Financial Statements and Exhibits.

(c)  Exhibits.

     Exhibit No.    Description of Exhibit                  Page

     99.1           Registrant's press release dated
                    February 12, 2004                        3-4


                            Signature


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                   COMPETITIVE TECHNOLOGIES, INC.
                                   Registrant


Date:  February 12, 2004           /s/  John B. Nano
                                   By:  John B. Nano
                                   President and
                                   Chief Executive Officer

EX-99.1

                                                     Exhibit 99.1


For Immediate Release:

WYETH APPEALS 10-YEAR OLD MATERNA LITIGATION TO SUPREME COURT

Fairfield, CT (February 12, 2004): Competitive Technologies, Inc.
(AMEX: CTT) announced that it has been advised that Wyeth (NYSE:
WYE) has filed an appeal to the Supreme Court of the United
States on the $58.2 million patent infringement judgment for
fraud and unjust enrichment against Wyeth, and in favor of CTT's
client, the University of Colorado.

On November 12, 2003, the US Court of Appeals for the Federal
Circuit denied a rehearing/rehearing en banc for this case of the
Court's September 3, 2003 affirmation of the August 13, 2002
decision of US Senior District Court Judge John Kane of the US
District Court for the District of Colorado.  A preliminary
opinion issued in July 2000 found that Drs. Robert H. Allen and
Paul A. Seligman at the University of Colorado, a CTT client, are
the sole inventors of the improved formulation of the prenatal
vitamin supplement, and that Wyeth had committed fraud and was
unjustly enriched.

John B. Nano, President and CEO of CTT said, "We fully anticipate
that the highest court in the nation will not hear a case already
decided by multiple decisions of the lower courts and will
continue to find in favor of the University et al to finally
close this litigation which began in 1993 for product sales
between 1984 and 1994.  Wyeth seems to be unfairly determined to
delay the resolution of the case after more than ten years."

Mr. Nano continued, "We had expected that in proper use of the
judicial process and a sense of fairness to the University, the
citizens of Colorado, and the doctors, that Wyeth would not
continue to appeal these judgements against their position.  SEC
filings indicate that Wyeth accrued a litigation reserve of
nearly $17 billion over the last several years.  According to
court filings they are involved in over 25,000 court cases."

The litigation involves a prenatal vitamin supplement marketed by
Wyeth under the Materna(TM) name.  The US District Court for the
District of Colorado and the US Court of Appeals for the Federal
Circuit found that Wyeth had committed fraud for unjust
enrichment.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the
technology needs of its customers and transforming those
requirements into commercially viable solutions.  CTT is a global
leader in identifying, developing and commercializing innovative
technologies in life, digital, nano, and physical sciences
developed by universities, companies and inventors.  The global
market for technology transfer services is estimated at $150
billion annually.  CTT maximizes the value of intellectual assets
for the benefit of its customers, clients and shareholders.
Visit CTT's website: http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in
this document other than historical facts are "forward-looking
statements" within the meaning of applicable Federal Securities
Laws and are not guarantees of future performance.  These
statements involve risks and uncertainties, including those set
forth in Item 1 of the Company's most recent Form 10-K and in
CTT's other filings with the SEC, and are subject to change at
any time.  The Company's actual results could differ materially
from these forward-looking statements.  The Company undertakes no
obligation to update publicly any forward-looking statement.

Direct inquiries to:     Johnnie D. Johnson, Strategic IR,Inc.
                         E-mail:   jdjohnson@strategic-ir.com
                         Tel.      (212) 754-6565;
                         Fax       (212) 754-4333
                         E-mail:   ctt@competitivetech.net